Covid increases the difference in job quality
Covid increases the difference in job quality

Covid increases the difference in job quality

Employers will need to design psychologically sound and safe work arrangements to overcome the risks of stress and burnout, which are more common today than before the Covid pandemic, experts say.

Jim Stanford

Jim Stanford, economist and director of the Center for Future Work, retweeted an article shared by Graham Lowe, a workplace consultant at The Graham Lowe Group, about the impact of Covid-19 on future work. He stresses that workers’ mental health problems have been exacerbated by the pandemic, which has led to stress, anxiety and burnout.

Lowe explains that the need to promote resilience in the form of agility and flexibility, which can help teams and individuals face the challenges of the pandemic at work, is crucial. Shutdowns posed new challenges for workforces worldwide, including the inability to cope with long working hours, for working parents struggling to balance their work and children.

As a result, some countries introduced constructive measures to address labor issues, such as the recent federal-provincial childcare funding commitments in Canada, Portugal’s initiative to ban employers from contacting their employees after work, and reduce the work week to four days instead of seven.

The pandemic has also widened the gap in job quality, with frontline and essential workers facing increased risks due to illness, stress and burnout, while white-collar workers quickly adapted to teleworking trends. Employers will therefore need to focus on dealing with health and safety risks, such as offering paid sick leave and improving the workplace’s mental health resources to close this gap, Lowe said.

Chad P Bown

Chad P Bown, a senior fellow at the Peterson Institute for International Economics (PIIE), a researcher at the Center for Economic and Policy Research (CEPR), and a non-resident fellow at the WTI, tweeted at the U.S. Food and Drug Administration (FDA) after have been authorized to export four additional batches of AstraZeneca’s Covid-19 vaccine outside the United States. The vaccines were produced at Emergent BioSolutions’ Baltimore plant, and are likely to be the latest round of updates the agency provides on the quarantine doses from the plant.

The FDA maintained that AstraZeneca’s Covid-19 vaccine was not approved for use in the United States, but will be exported outside the United States after careful review of the manufacturer’s plant records and quality test results. The initiative aimed to meet the current global demand for Covid-19 vaccines.

The problem arose when drug substance from Johnson & Johnson’s (J&J) Covid-19 vaccine batch was contaminated during a mix with AstraZeneca’s viral vectors at the company’s Bayview plant. This resulted in 15 million doses of the J&J Covid-19 shot being destroyed and 60 million doses being discarded as the FDA isolated and tested multiple doses.

Dean Baker

Dean Baker, senior economist at the Center for Economic and Policy Research (CEPR), retweeted an article shared by Haley Brown, a research fellow at CEPR, about the Centers for Disease Control and Prevention (CDC), which retains much of Covid-19 data related to boosters, hospitalizations and most recently wastewater analyzes due to concerns about abuse or misrepresentations.

Brown tweeted that this was an unacceptable reason to hide critical information about the virus crisis, similar to, for example, the Bureau of Labor Statistics (BLS) choosing not to release financial data to stay away from misinterpretation. It is speculated that a government authority has been collecting huge data on Covid admissions for more than a year now, but has not disclosed the information to the public.

It is also believed that when the agency published the first significant data on boosters and its effectiveness in adults younger than 65 years ago two weeks ago, it left out a large proportion of the population, ie 18 to 49-year-olds, who are least likely to take advantage of booster shots.

The CDC also recently introduced a dashboard with wastewater data on its website, which will include daily updates and early information on an increase in the Covid-19 infection rate. It is believed that some US states and territories had shared wastewater information with the agency since the beginning of the pandemic, but these results were never published before.

Related companies




Leave a Reply

Your email address will not be published.